Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

about

Anti‑IL‑39 (IL‑23p19/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupus‑like mice.

Item

http://www.wikidata.org/entity/Q47401182

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anti‑IL‑39 (IL‑23p19/Ebi3) pol ...... e symptoms in lupus‑like mice.

@en

Anti‑IL‑39

@nl

type

Item

label

Anti‑IL‑39 (IL‑23p19/Ebi3) pol ...... e symptoms in lupus‑like mice.

@en

Anti‑IL‑39

@nl

prefLabel

Anti‑IL‑39 (IL‑23p19/Ebi3) pol ...... e symptoms in lupus‑like mice.

@en

Anti‑IL‑39

@nl

P1476

Anti‑IL‑39 (IL‑23p19/Ebi3) pol ...... e symptoms in lupus‑like mice.

@en

P2093

Beifen Shen

http://www.w3.org/2001/XMLSchema#string

Chunmei Hou

http://www.w3.org/2001/XMLSchema#string

Gaizhi Zhu

http://www.w3.org/2001/XMLSchema#string

Gencheng Han

http://www.w3.org/2001/XMLSchema#string

Guojiang Chen

http://www.w3.org/2001/XMLSchema#string

He Xiao

http://www.w3.org/2001/XMLSchema#string

Ning Ma

http://www.w3.org/2001/XMLSchema#string

Renxi Wang

http://www.w3.org/2001/XMLSchema#string

Tianxiao Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoling Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Neutrophils contribute to excess serum BAFF levels and promote CD4+ T cell and B cell responses in lupus-prone mice.

Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.

IL-12 family cytokines: immunological playmakers

BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.

Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE.

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.

P304

1660-1666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.8048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29138852

http://www.w3.org/2001/XMLSchema#string

P932

5780108

http://www.w3.org/2001/XMLSchema#string